Article Data

  • Views 1077
  • Dowloads 142

Original Research

Open Access

Differential gene expression profile reveals overexpression of MAP3K8 in invasive endometrioid carcinoma

  • C. Aparecida Alves1
  • I.D.C.G. Silva1,*,
  • F.E. Villanova1
  • S. Mancini Nicolau1
  • M.A. Custodio1
  • C. Bortoletto1
  • W.J. Goncalves1

1Gynecology Department, Federal University of Sao Paulo, SP, Brazil

DOI: 10.12892/ejgo200606589 Vol.27,Issue 6,November 2006 pp.589-593

Published: 10 November 2006

*Corresponding Author(s): I.D.C.G. Silva E-mail:

Abstract

Gene microarray technology is highly effective in screening for differential gene expression and has hence become a popular tool in the molecular investigation of cancer. In the present study, cDNA microarrays containing 2,000 different genes were used to analyze gene expression profiles in ten human postmenopausal endometrioid-paired carcinoma specimens versus corresponding adjacent normal tissue to identify differentially expressed genes. In our study several genes were found differentially expressed. One of them was the MAP3K8, a gene that has never been described to be overexpressed in this kind of malignancy. To validate the differential expression of this gene as well as the membrane array, we performed semiquantitative reverse transcription-PCR analysis. MAP3K8 was found overexpressed in 30% of the endometrial carcinoma samples. To the best of our knowledge this is the first report showing the MAP3K8 oncogene linked to human endometrial carcinoma suggesting that it may be another molecule involved in human endometrial cancer.

Keywords

cDNA array; Endometrial carcinoma; MAP3K8

Cite and Share

C. Aparecida Alves,I.D.C.G. Silva,F.E. Villanova,S. Mancini Nicolau,M.A. Custodio,C. Bortoletto,W.J. Goncalves. Differential gene expression profile reveals overexpression of MAP3K8 in invasive endometrioid carcinoma. European Journal of Gynaecological Oncology. 2006. 27(6);589-593.

References

[1] Bristow R.E.: "Endometrial Cancer". Curr. Opin. Oncol., 1999, 11, 388.

[2] Lima G.R., Gebrim L.H., Oliveira V.C., Martins N.V "Endometrium Cancer". Gynecologic Oncology. 1999, ed. Sao Paulo, Atheneu, 326.

[3] Risinger J.I., Maxwell G.L., Chandramouli G.V., Jazaeri A., Aprelikova O., Patterson T., Berchuck A., Barret J.C.: "Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer". Cancer Res., 2003, 63, 6.

[4] Kao L.C., Tulac S., Lobo S., lmani B., Yang J.P., Germeyer A. et al.: "Global gene profiling in human endometrium during the window of implantation". Endocrinology, 2002, 143, 2119.

[5] Brentani H., Caballero O.L., Camargo A.A. et al.: "The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags". Proc. Natl Acad. Sci USA, 2003, 100. 13418.

[6] Miller R.G. Jr.: "Beyond ANOVA: Basics of Applied Statistics" 1977, New York, Chapman & Hall.

[7] Westfall P.H., Young S.S.: "Resampling-based Multiple Testing: Examples and Methods for P-Value Adjustment". 1993, New York, John Wiley & Sons.

[8] Dudoit S., Yang Y.H., Callow M.J., Speed T.P.: "Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments". Stat. Sin., 2002, 12, 111.

[9] Miyoshi J., Higashi T., Mukai H., Ohuchi T., Kakunaga T.: "Structure and transforming potential of the human cot oncogene encoding a putative protein kinase". Malec. Cell. Biol., 1991, 11, 4088.

[10] Chan A.M.L., Chedid M., Mcgovern E.S., Popescu N.C., Miki T., Aaronson S.A.: "Expression cDNA cloning of a serine kinase transforming gene". Oncogene, 1993, 8, 1329.

[11] Clark M.A., Reynolds S.H., Anderson M., Wiest J.S.: "Mutational activation of the MAP3K8 protooncogene in lung cancer". Genes., Chromos. Cancer, 2004, 41, 99.

[12] Chiariello M., Marinissen M.J., Gutkind J.S.: "Multiple mitogenactivated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation molecular and cellular". Biology, 2000, 20, 1747.

Submission Turnaround Time

Top